ASAMS WEBSITE - Reload site / Break frames

SEARCH THE SITE

ABOUT ARACHNOIDITIS
IN THE NEWS
INFORMATION FOR PATIENTS AND FRIENDS
INFORMATION FOR THE MEDICAL PROFESSIONAL
ALTERNATIVE AND COMPLIMENTARY THERAPIES
PATIENTS' STORIES
ARACHNOIDITIS PIONEERS
LINKS TO RELATED WEBSITES
MESSAGE BOARDS

ABOUT THIS WEBSITE
PRIVACY POLICY
LEGAL NOTICES

Kiwiwebs - Boutique Web Design & Management

 
B.P.A.A. News Letter - Spring 1996
Volume 4, Number 2 (Page 6)

Margaret A. Hill

Long did not find a consistent clinical pattern of symptoms. Instead he found the following: 302 patients (94%) had back pain that was aggravated by activity; 261 patients (81%) had leg pain; 40% had radicular pain and 41% had diffuse and apparently nonradicluar pain; 45 patients (14%) had major bowel and bladder dysfunction. The arachnoiditis was progressive in six patients (1.8%). Range of trunk motion was impaired in 292 patients (91%); forward and backward bending produced pain in all patients; chronic muscle contractions (usually secondary to surgery) were present in 301 patients (94%);motor loss in 237 (74%) and demonstrable sensory loss in 261 (81%); reflex changes were present in 308 (96%); straight leg raising was positive in 195 (61%).

 

Functional status was assessed by questioning the patients: 269 patients (84%) walked alone; 48 (15%) walked with aids; 1.2% were wheelchair bound; 295 (92%) complained of claudication with limitation of the distance they could walk; 36 (11%) were working full-time; 118 (37%) were working part-time or with limitations;

167 were retired secondary to back complaints (but could not be directly attributed to arachnoiditis in most); 82% drove without limitation; 12% were able to drive an automobile with aids; only 18 (5.6%) were unable to drive.

 

Sexual function was severely impaired. Only 8% described no abnormalities; 147 (45%) were able to perform sexually with impairment; 151 (47%) described severe impairment of sexual function.

 

Forty-five patients (14%) were taking no drugs of any kind and 64 (19%) were using non-narcotic analgesics (often in large quantities).

One patient sustained severe kidney damage from Propoxyphene (DarvonÒ) and two patients were found to have significant hepatic damage from the use of non-steroidal anti-inflammatory drugs; 167 (52%) used narcotics on a daily basis; 45 (14%) showed evidence of abuse and drug seeking behavior; 260 (81%) used a psychotropic drug, diazepam being the most common.

 

In the patients with spinal cord involvement, all had blocks on myelography; all had progressive neurological deficits; 2 with cervical arachnoiditis were quadriplegic with increasing respiratory deficiencies.

Patients with thoracic cord involvement were all becoming progressively paraplegic.

 

Therapy: Of the original 158 patients, 23 underwent microlysis of the adhesions, and 14, direct surgery upon an extradural defect without therapy of the arachnoiditis; 3 were given repetitive intrathecal steroids and in one patient, oral steroids were given as well; 32 patients were treated with spinal cord stimulation; 131 underwent in patient pain rehabilitation to maximize function while reducing drug utilization

 

In the second group of 163 patients, 12 underwent microlysis of the adhesions; 47 were operated on directly for other extradural problems; 42 were referred for spinal cord stimulation; one had an unsuccessful trial of brain stimulation; one was treated with intrathecal steroid injections; one had an intrathecal morphine pump; 72 were referred for inpatient pain rehabilitation.

 

Previous Page | Next Page
Jump to page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17

 

 

 

Home (Reload site / Break Frames) | About This Website | E-mail the Webmaster

Copyright © 2000 Arachnoiditis Sufferers Action and
Monitoring Society
(ASAMS) New Zealand Incorporated
We have made every attempt to seek permission for info on this site and appreciate the support received. Please do not reproduce without permission as it may affect our ability to provide information in the future.